BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology Today - ECPv6.16.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology Today
X-ORIGINAL-URL:https://oncologynewstoday.co.uk
X-WR-CALDESC:Events for Oncology Today
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260225T090000
DTEND;TZID=Europe/London:20260225T170000
DTSTAMP:20260120T100413Z
CREATED:20260120T100413Z
LAST-MODIFIED:20260120T100413Z
UID:8344-1772010000-1772038800@oncologynewstoday.co.uk
SUMMARY:General Haematology in Practice Study Day
DESCRIPTION:General Haematology in Practice: Developing knowledge and confidence in general haematology care across all settings Wed 25th Feb 2026 \n\n\n\n\nGeneral Haematology in Practice Hybrid Study \nDeveloping knowledge and confidence in general haematology care across all settings \nOverview \nHere at the Christie Haematology at Satellite Centres we deal with a range of Haematology issues covering blood morphology\, haemostasis\, ITP\, Lymphadenopathy\, Haemoglobinopathy and all associated symptoms. This study day will give delegates an understanding how blood functions\, how it is produced and various pathologies associated with haematology and will highlight common conditions treated such as anaemias\, blood cancers\, bleeding and clotting disorders. \nIntended Audience \nPrimary Care – GP`s\, District Nurse\, community team ( IV teams) \nSecondary Care- ward / junior Drs\, nurses\, AHP’s\, CNS teams \nTertiary Care- newly qualified nurses\, AHP’s\, refresher for existing staff \nAlso\, any other healthcare professionals interested in the different general haematology pathways \nWhat to expect \n\nHaematology Techniques and Blood Cell Morphology- Understanding day to day blood test investigations in primary and secondary care\nAnaemia\, Leukopenia & Thrombocytopenia\nHaemostasis & Thrombosis\nITP- Diagnosis & Management\nLymphadenopathy & Splenomegaly\nHaematological Malignancies\nHaemoglobinopathies\nTopical case Studies\n\nKey Outcomes \n\nEnhance Knowledge– an opportunity to deepen your understanding of haematology pathways and related diseases\nProfessional Development – platform for professionals to learn from experts and improve their skills in haematology\nNetworking Opportunities – connect with haematology leads & experts in their field\nSupport for patients – Knowledge gained can be applied directly to patients care and pathway strategies\n\nJoin Your Colleagues: \n\nIn-person: Education Centre\, The Christie (easy access via local transport links)\nVirtual: Participate from your workplace\nCatch-up access: 6-month replay available – perfect for busy clinical schedules\n\nAgenda \nPlease see below \nPlease note: one livestream ticket purchase is equivalent to one CPD certificate and the name on the ticket will match the one on the booking registration. Where the ‘5 for 4’ ticket option is purchased\, we will contact you directly to ask for the 5 names for the certificates. Further details can be found in our T&C’s further down this page. \nVenue Information \nThe Christie Education Centre is located on the 2nd floor in Dept 17 of the main hospital and can be accessed by stairs or lift. Toilets are also on this floor including an accessible toilet. The auditorium has a hearing loop available and ramp access. A prayer room is available and close by. We want everyone attending our event in person to have the best possible experience. We provide regular breaks\, access to quiet spaces etc\, but If there is anything else we can do to make the day/your experience more comfortable\, please let us know by either completing this form\, Inclusive learning support or emailing us: the-christie.learner.support@nhs.net \nPlease see our booking Terms and Conditions here \nClick here to read our privacy policy: http://www.christie.nhs.uk/professionals/education/continuing-professional-development/study-days-and-conferences/school-of-oncology-events-privacy-policy/ \nThis event may be subject to change from Hybrid to fully virtual. Correspondence in regards to any changes in the delivery of this event will be notified directly by The Christie Insttute for Cancer Education. \nEmail the-christie.educationevents@nhs.net or call +44 (0) 161 918 7409
URL:https://oncologynewstoday.co.uk/event/general-haematology-in-practice-study-day-2/
LOCATION:The Christie School of Oncology\, 550 Wilmslow Road\, Manchester\, M20 4BX\, United Kingdom
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260224T080000
DTEND;TZID=Europe/London:20260226T170000
DTSTAMP:20260120T094443Z
CREATED:20260120T094443Z
LAST-MODIFIED:20260120T094443Z
UID:8339-1771920000-1772125200@oncologynewstoday.co.uk
SUMMARY:Data-Driven Cancer Research Conference
DESCRIPTION:Building on the success of our sold-out 2024 inaugural event\, we’ve expanded the conference to a three-day programme. We’ll be exploring the future of data-enabled cancer research\, highlighting the transformational role of emerging tools and technologies in advancing our understanding of cancer. Each day is dedicated to a specific theme: \n\n\nDay 1 – Exploring the future of data-driven cancer research \n\n\nDay 2 – Revolutionising cancer research: the transformative role of AI \n\n\nDay 3 – Personalising cancer medicine: the power of health data \n\n\nThroughout the event\, we will also focus on how we can build vital trust and transparency regarding the use of patient data through patient and public involvement and engagement. Additionally\, we’ll work together to address data solutions to shared challenges in children’s and young people’s cancers. \nThis is a must-attend event for anyone working in cancer research\, data science\, bioinformatics\, computational oncology\, computer science\, mathematics or statistics\, including those working at the interface between these disciplines. The event is open to researchers from all career stages from across the world.
URL:https://oncologynewstoday.co.uk/event/data-driven-cancer-research-conference/
LOCATION:Edinburgh International Conference Centre
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260223T090000
DTEND;TZID=Europe/London:20260226T170000
DTSTAMP:20260118T150906Z
CREATED:20260118T150906Z
LAST-MODIFIED:20260118T150906Z
UID:8329-1771837200-1772125200@oncologynewstoday.co.uk
SUMMARY:16th World ADC London 
DESCRIPTION:16th World ADC London \n23rd – 26th February 2026 | London\, UK \nReturning as the longest-standing and definitive ADC forum in Europe\, the 16th World ADC London Summit is the week for anyone working in or interested to learn about bioconjugates. Leverage cutting-edge R&D\, development strategy\, and unparalleled networking opportunities to harness ADC innovation and maximise the therapeutic index of your ADCs. \nWith 5 streams of end-to-end content spanning discovery\, preclinical and translation\, clinical lessons\, process and analytical development\, and manufacturing and supply chain: the 2026 agenda has been infused with trailblazing design\, development\, and production innovations to overcome patient resistance mechanisms and push ADCs to earlier line oncology treatments. \nJoin 115+ ADC Expert Speakers from leading companies including AbbVie\, Eli Lilly\, Pfizer\, Astellas Pharma\, Daiichi-Sankyo\, AstraZeneca\, GSK and many more to harness Global ADC Innovation to Redefine Precision Cancer Treatment in Europe. \nUniting 800+ senior European ADC decision-makers across biopharma\, clinicians\, service providers\, investors\, and regulators\, World ADC London is proud to bring the community together to kick off 2026 and shape the future of ADC development. \nSee more here – https://ter.li/g1i8h8 \nP.S. Register today and access your 10% discount code\, exclusively for the Oncology News Today audience – ONT6289710 \nDiscover the full 2026 programme and registration details here –https://ter.li/n0zzoj
URL:https://oncologynewstoday.co.uk/event/16th-world-adc-london/
LOCATION:Excel London Royal Victoria Dock\, 1 Western Gateway London\, E16 1XL United Kingdom\, United Kingdom
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260223T090000
DTEND;TZID=Europe/London:20260223T170000
DTSTAMP:20260120T094852Z
CREATED:20260120T094852Z
LAST-MODIFIED:20260120T094852Z
UID:8342-1771837200-1771866000@oncologynewstoday.co.uk
SUMMARY:SACT in Motion- Your Care\, Your Community\, Your Home
DESCRIPTION:Join us on the 23rd February 2026 for the SACT in Motion Hybrid Study Day. This event is Hybrid \n\n\n\n\nJoin us for an exciting and insightful SACT Study Day\, where we dive into the evolving landscape of delivering SACT services at The Christie and beyond in the community across Greater Manchester. \nThis day highlights how every part of the pathway plays a crucial role in improving patient experience and outcomes. Hear an honest account of some of the challenges of working throughout Greater Manchester across multiple sites and receive an insight into how our innovative and dynamic teams manage this. \nDiscover the breadth and depth of services\, including: \n\nThe Oak Road Treatment Centre (ORTC)– at the heart of high-quality cancer care\nChristie Outreach & Peripheral Sites – bringing care closer to communities\nThe evolving Oral SACT Service\nChristie at Home – transforming how and where patients receive treatment\n\nGain insight into how we’re managing: \n\nYear-on-year growth in treatment activity\nExpanding approvals for cutting-edge therapies through horizon scanning\nService development\, workforce expansion\, and operational resilience\nLogistical issues and solutions\nManaging capacity and demand through GM\n\nLearn about: \n\nInvesting in a growing and dynamic workforce\nInnovative approaches to staff education and upskilling\nStrategies to meet future demand while staying true to the “Christie Closer to Home” ethos\n\nWhether you’re clinical\, operational\, or strategic\, this is your opportunity to learn from experienced colleagues about advancing SACT delivery across integrated healthcare systems. \nJoin Your Colleagues: \n\nIn-person: Education Centre\, The Christie (easy access via local transport links)\nVirtual: Participate from your workplace\nCatch-up access: 6-month replay available – perfect for busy clinical schedules\n\nThis is your opportunity to gain practical insights and strategies that you can adapt for your local patients and services\, while connecting with healthcare professionals. Reserve your place to learn from colleagues who are pioneering innovative cancer care delivery models. \nPlease note: one livestream ticket purchase is equivalent to one CPD certificate and the name on the ticket will match the one on the booking registration. Where the ‘5 for 4’ ticket option is purchased\, we will contact you directly to ask for the 5 names on the certificates. Further details can be found in our T&C’s further down this page. \nVenue Information \nThe Christie Education Centre is located on the 2nd floor in Dept 17 of the main hospital and can be accessed by stairs or lift. Toilets are also on this floor including an accessible toilet. The auditorium has a hearing loop available and ramp access. A prayer room is available and close by. We want everyone attending our event in person to have the best possible experience. We provide regular breaks\, access to quiet spaces etc\, but If there is anything else we can do to make the day/your experience more comfortable\, please let us know by either completing this form\, Inclusive learning support or emailing us: the-christie.learner.support@nhs.net \nPlease see our booking Terms and Conditions here \nClick here to read our privacy policy: http://www.christie.nhs.uk/professionals/education/continuing-professional-development/study-days-and-conferences/school-of-oncology-events-privacy-policy/ \nT his event may be subject to change from Hybrid to fully virtual. Correspondence in regards to any changes in the delivery of this event will be notified directly by The School of Oncology. \nEmail the-christie.educationevents@nhs.net or call +44 (0) 161 918 7409
URL:https://oncologynewstoday.co.uk/event/sact-in-motion-your-care-your-community-your-home-2/
LOCATION:The Christie School of Oncology\, 550 Wilmslow Road\, Manchester\, M20 4BX\, United Kingdom
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260223T090000
DTEND;TZID=Europe/London:20260223T170000
DTSTAMP:20251114T113423Z
CREATED:20251114T113423Z
LAST-MODIFIED:20251114T113423Z
UID:8112-1771837200-1771866000@oncologynewstoday.co.uk
SUMMARY:SACT in Motion- Your Care\, Your Community\, Your Home
DESCRIPTION:Join us on the 23rd February 2026 for the SACT in Motion Hybrid Study Day. This event is Hybrid \nJoin us for an exciting and insightful SACT Study Day\, where we dive into the evolving landscape of delivering SACT services at The Christie and beyond in the community across Greater Manchester. \nThis day highlights how every part of the pathway plays a crucial role in improving patient experience and outcomes. Hear an honest account of some of the challenges of working throughout Greater Manchester across multiple sites and receive an insight into how our innovative and dynamic teams manage this. \nDiscover the breadth and depth of services\, including: \n\nThe Oak Road Treatment Centre (ORTC)– at the heart of high-quality cancer care\nChristie Outreach & Peripheral Sites – bringing care closer to communities\nThe evolving Oral SACT Service\nChristie at Home – transforming how and where patients receive treatment\n\nGain insight into how we’re managing: \n\nYear-on-year growth in treatment activity\nExpanding approvals for cutting-edge therapies through horizon scanning\nService development\, workforce expansion\, and operational resilience\nLogistical issues and solutions\nManaging capacity and demand through GM\n\nLearn about: \n\nInvesting in a growing and dynamic workforce\nInnovative approaches to staff education and upskilling\nStrategies to meet future demand while staying true to the “Christie Closer to Home” ethos\n\nWhether you’re clinical\, operational\, or strategic\, this is your opportunity to learn from experienced colleagues about advancing SACT delivery across integrated healthcare systems. \nJoin Your Colleagues: \n\nIn-person: Education Centre\, The Christie (easy access via local transport links)\nVirtual: Participate from your workplace\nCatch-up access: 6-month replay available – perfect for busy clinical schedules\n\nONCOLOGYNT – For 10% off
URL:https://oncologynewstoday.co.uk/event/sact-in-motion-your-care-your-community-your-home/
LOCATION:Education Centre (Dept 17) The Christie\, 550 Wilmslow Road\, Manchester\, M20 4BX
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260205T090000
DTEND;TZID=Europe/London:20260205T170000
DTSTAMP:20260120T101146Z
CREATED:20260120T101146Z
LAST-MODIFIED:20260120T101146Z
UID:8348-1770282000-1770310800@oncologynewstoday.co.uk
SUMMARY:The Royal Marsden GI Updates in Oesophagogastric Cancers
DESCRIPTION:We will focus on the latest evidence base in the managements of these aggressive cancers\, surgical and oncological considerations\, and technological advances. The participants will leave the meeting with clear concepts on current management and ongoing research which will likely change future practice. \nOur invitation is extended to medical\, surgical\, nursing and allied health professionals\, and members of the multidisciplinary team\, and to those based in primary\, secondary or tertiary care settings. \nCPD accreditation applied for from The Royal College of Physicians 
URL:https://oncologynewstoday.co.uk/event/the-royal-marsden-gi-updates-in-oesophagogastric-cancers/
LOCATION:The Royal Marsden Education and Conference Centre\, Chelsea\, Stewart's Grove\, London\, SW3 6JJ\, United Kingdom
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260203T090000
DTEND;TZID=Europe/London:20260203T160000
DTSTAMP:20260120T100816Z
CREATED:20260120T100816Z
LAST-MODIFIED:20260120T100816Z
UID:8346-1770109200-1770134400@oncologynewstoday.co.uk
SUMMARY:Demystifying the Science Behind Targeted Treatments and Immunotherapies for Haematological Cancers
DESCRIPTION:This course introduces the biology and genetics of many haematological cancers. Elaine also describes a wide range of systemic treatment approaches for acute and chronic leukaemia\, non-Hodgkin and Hodgkin lymphoma\, and multiple myeloma. These include monoclonal antibody-\, small molecule- and cell-based therapies. Because of their complexity\, Elaine will pay particular attention to CAR T cell therapy and T cell engagers. \nThis content is ideal for research nurses\, clinical nurse specialists\, pharmacists and clinical trials coordinators. It may also be of interest to other healthcare professionals involved in the diagnosis and treatment of people with haematological cancers\, and to junior doctors.
URL:https://oncologynewstoday.co.uk/event/demystifying-the-science-behind-targeted-treatments-and-immunotherapies-for-haematological-cancers-2/
LOCATION:The Royal Marsden Education and Conference Centre\, Chelsea\, Stewart's Grove\, London\, SW3 6JJ\, United Kingdom
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260127T080000
DTEND;TZID=Europe/London:20260129T170000
DTSTAMP:20251128T124245Z
CREATED:20251128T124245Z
LAST-MODIFIED:20251128T124245Z
UID:8175-1769500800-1769706000@oncologynewstoday.co.uk
SUMMARY:9th DDR Inhibitors Summit
DESCRIPTION:The 9th DDR Inhibitors Summit returns to Boston in 2026 as the leading event uniting biopharma\, biotech\, and academia to advance next-generation DNA Damage Response (DDR)-targeted therapies beyond PARP. With growing clinical momentum for ATR\, CHK1/2\, WEE1\, and DNA-PK inhibitors\, this 3-day meeting delivers cutting-edge insights on biomarker-driven discovery\, translational strategy\, and combination approaches. Featuring 30+ expert speakers from Artios Pharma\, AstraZeneca\, Merck\, and others\, attendees will benchmark programs\, explore innovations\, and network with global DDR leaders shaping the future of precision oncology through synthetic lethality and safer\, more effective cancer treatments.
URL:https://oncologynewstoday.co.uk/event/9th-ddr-inhibitors-summit/
LOCATION:Boston\, MA\, Hilton Boston Back Bay\, 40 Dalton Street\, Boston\, MA\, MA 02115\, United States
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260126T090000
DTEND;TZID=Europe/London:20260127T160000
DTSTAMP:20251114T110316Z
CREATED:20251114T110316Z
LAST-MODIFIED:20251114T110316Z
UID:8110-1769418000-1769529600@oncologynewstoday.co.uk
SUMMARY:An Introduction to cancer : Anatomy\, Biology and treatments
DESCRIPTION:Overview \nThis is a two day course which will present a basic understanding of cancer. Through a series of presentations David describes how cancer develops\, the commonest types of cancer\, cancer detection and treatment modalities. \nIntended Audience \nAll those new to and in early careers in Oncology including Research\, CTU\, Admin support\, Doctors\, Nurses\, AHP’s\, Hospice\, Industry Colleagues and any other staff groups who require an understanding of the anatomy\, biology and treatments of cancer. \nTopics Covered \n\nIntroduction to cells\, tissues and cancer\nThe spread of cancer\nClassification of cancer\nOverview of treatment options for cancer\nColorectal cancer\nLeukaemia and lymphoma\nLung cancer\nBreast and Prostate cancer
URL:https://oncologynewstoday.co.uk/event/an-introduction-to-cancer-anatomy-biology-and-treatments-2/
LOCATION:Education Centre (Dept 17) The Christie\, 550 Wilmslow Road\, Manchester\, M20 4BX
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260122T090000
DTEND;TZID=Europe/London:20260122T170000
DTSTAMP:20251114T105033Z
CREATED:20251114T105033Z
LAST-MODIFIED:20251114T105033Z
UID:8108-1769072400-1769101200@oncologynewstoday.co.uk
SUMMARY:Modern Cancer Pain Management
DESCRIPTION:Overview \nAdvances in cancer treatments mean that more people are living longer\, even with incurable disease. This has uncovered a need to review our approach to cancer pain management \, ensuring that care is more personalised and consistent with the stage of disease. This course brings together expertise in the cancer pain field to provide an up-to-date view on current best practice. \nWhat to expect \n\nManaging chronic cancer pain – what’s the evidence?\nHow to manage immunotherapy-induced joint pains\nBone pain: what are the options?\nFast-acting fentanyls: when to use and how often)\nPain interventions: are they still relevant in cancer pain control?\nLong-term consequences of cancer treatment: how to manage and by who?\nOpioid-related harm in palliative care\nThe unknown unknowns: pharmacological and non-pharmacological therapy\nIntegrative oncology and its role in pain management\n\nONCOLOGYNT – For 10% off
URL:https://oncologynewstoday.co.uk/event/modern-cancer-pain-management/
LOCATION:The Christie NHS Foundation Trust\, 550 Wilmslow Road\, Manchester\, M20 4BX\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260122T080000
DTEND;TZID=Europe/London:20260122T170000
DTSTAMP:20260122T160217Z
CREATED:20260122T160217Z
LAST-MODIFIED:20260122T160217Z
UID:8381-1769068800-1769101200@oncologynewstoday.co.uk
SUMMARY:Wales Cancer Research Conference 2026
DESCRIPTION:An annual conference that brings together cancer researchers and stakeholders from across the UK. \nThe Wales Cancer Research Conference is an opportunity for cancer researchers in Wales to convene across specialties\, institutions and research areas. With speakers from Wales and the UK\, presentations will cover the latest advances in cancer research\, and opportunities to connect with colleagues will help to stimulate future partnerships. \nOn Monday 23 March 2026 we will be holding our third Wales Cancer Research Conference at the Vale Resort in Hensol\, The Vale of Glamorgan \n  \n 
URL:https://oncologynewstoday.co.uk/event/wales-cancer-research-conference-2026/
LOCATION:Vale Resort in Hensol\, The Vale of Glamorgan
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260113T090000
DTEND;TZID=Europe/London:20260113T170000
DTSTAMP:20251114T104742Z
CREATED:20251114T104742Z
LAST-MODIFIED:20251114T104742Z
UID:8106-1768294800-1768323600@oncologynewstoday.co.uk
SUMMARY:Metastatic Breast Cancer Study Day
DESCRIPTION:Overview \nThis study day will focus on important approaches to management of patients with secondary (or metastatic) breast cancer. \nTopics will include all aspects of the patient pathway\, Including recent advances in systemic and local therapies for secondary breast cancer. There will also be sessions on the prevention and management of treatment toxicities. \nTarget audience \nOncology professionals (including allied health professionals\, pharmacists and nurses) and General Practitioners working with Secondary Breast Cancer patients \nWhat to expect \nLeaders in their respective fields will present updates on the management of early breast cancer of all major subtypes: HER2+\, triple negative & hormone receptor positive. Session will be interactive to facilitate learning. \nONCOLOGYNT – For 10% off
URL:https://oncologynewstoday.co.uk/event/metastatic-breast-cancer-study-day/
LOCATION:The Christie NHS Foundation Trust\, 550 Wilmslow Road\, Manchester\, M20 4BX\, United Kingdom
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251212T090000
DTEND;TZID=Europe/London:20251212T170000
DTSTAMP:20251126T154218Z
CREATED:20251126T154218Z
LAST-MODIFIED:20251126T154218Z
UID:8171-1765530000-1765558800@oncologynewstoday.co.uk
SUMMARY:BIR/HLH Lung cancer screening study day 2025
DESCRIPTION:HLH ccEvent Overview \n\n\nDate: 12 December 2025 \nTime: 9am – 5pm \nVenue: America Square\, Cavendish Venues \nCPD: 6 credits \nA one-day in-person study day hosted by The HLH Imaging Group (HLH) focusing on the end-to-end process for lung cancer screening (LCS) in the UK. This programme brings together shared multidisciplinary learning from NHS Lung Cancer Screening (LCS) sites as well as offering insights on the potential rollout of a national lung cancer screening programme. \nWho should attend? \nThe event is open to all multidisciplinary TLHC/lung cancer pathway stakeholders including: clinical radiologists who report on LCS; respiratory physicians; TLHC programme managers and Cancer Alliance Leads radiology trainees; CT radiographers; TLHC nurses; thoracic pathologist and thoracic surgeons.
URL:https://oncologynewstoday.co.uk/event/bir-hlh-lung-cancer-screening-study-day-2025/
LOCATION:America Square\, Cavendish Venues\, United Kingdom
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251210T080000
DTEND;TZID=Europe/London:20251212T170000
DTSTAMP:20251027T152433Z
CREATED:20251027T152433Z
LAST-MODIFIED:20251027T152433Z
UID:8047-1765353600-1765558800@oncologynewstoday.co.uk
SUMMARY:ESMO Immuno-Oncology Congress 2025
DESCRIPTION:Save the date for the ESMO Immuno-Oncology Congress 2025\, taking place from 10 until 12 December 2025 as an onsite event in London\, UK\, as well as online.\n\n\n\n\nThis international event provides valuable knowledge: from basic science to translational research and clinical development\, cutting-edge science\, and excellent networking opportunities. \nTake part in this meeting to learn\, share your research and expertise and connect with the stakeholders that are making a difference in the field. \n\n\n\n\n\n\nLearning objectives\n\nAccess immersion sessions in immunobiology and immuno-oncology translational research insights\nReview state of the art\, checkpoint inhibitor-based therapeutic strategies in immuno-oncology\nUnderstand recent developments in immune modulation\, including tumour microenvironment\, immunometabolism\, epigenetics and cell signalling\nConnect with Industry and independent investigators for an overview of  research and development in immuno-oncology\, including cellular therapies\, vaccines and immune modulators\, intratumoural immunotherapy and multispecific constructs
URL:https://oncologynewstoday.co.uk/event/esmo-immuno-oncology-congress-2025/
LOCATION:Queen Elizabeth II Centre\, QEII Centre\, London\, SW1P 3EE
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251209T200000
DTEND;TZID=Europe/London:20251209T210000
DTSTAMP:20251126T153515Z
CREATED:20251126T153515Z
LAST-MODIFIED:20251126T153515Z
UID:8168-1765310400-1765314000@oncologynewstoday.co.uk
SUMMARY:BAHNOhow? Session 3: Mental Health in Head & Neck Cancer – The MDT Role
DESCRIPTION:This third session in the BAHNO MDT Interface Series focuses on the challenge of mental health in Head & Neck Cancer. It will explore how members of the MDT can recognise\, discuss\, and respond to mental health concerns in their patients. \nKey Topics \n• The relationship between mental health and head & neck cancer – prevalence\, impact on outcomes\, and vice versa \n• Role of Clinical Psychology \n• How to ask about and acknowledge mental health issues in clinic \n• Responding to risk: what to do if a patient mentions suicidal thoughts \n• Signposting\, escalation\, and practical MDT strategies \n• Panel discussion and live Q&A \nSpeakers \nElspeth Desert – Consultant Clinical Psychologist \nJane Anderson – Senior lecturer in Advaned Clinical Practice (Mental Health) \nWho Should Attend: All members of the Head & Neck Cancer MDT who want to build confidence in recognising and addressing mental health challenges.
URL:https://oncologynewstoday.co.uk/event/bahnohow-session-3-mental-health-in-head-neck-cancer-the-mdt-role/
LOCATION:Online
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251204T090000
DTEND;TZID=Europe/London:20251204T170000
DTSTAMP:20251114T104408Z
CREATED:20251114T104408Z
LAST-MODIFIED:20251114T104408Z
UID:8104-1764838800-1764867600@oncologynewstoday.co.uk
SUMMARY:Bladder Oncology Study Day
DESCRIPTION:Overview \nThis multidisciplinary educational event brings together renowned experts and healthcare professionals to explore the rapidly evolving landscape of bladder cancer management. As one of the most common urological malignancies\, bladder cancer presents unique challenges requiring coordinated care across multiple specialties. Our study day addresses critical developments in molecular diagnostics\, emerging therapeutic approaches\, and patient-centred care strategies that are transforming outcomes for patients \nWhat to expect \n\nApply current evidence-based approaches to bladder cancer management\nIntegrate new diagnostic and therapeutic strategies into clinical practice\nEnhance multidisciplinary team collaboration\nImprove patient counselling and shared decision-making\n\n  \nJoin Your Colleagues: \n\nIn-person: Education Centre\, The Christie (easy access via local transport links)\nVirtual: Participate from your workplace\nCatch-up access: 6-month replay available – perfect for busy clinical schedules\n\nONCOLOGYNT – For 10% off
URL:https://oncologynewstoday.co.uk/event/bladder-oncology-study-day-2/
LOCATION:The Christie School of Oncology\, 550 Wilmslow Road\, Manchester\, M20 4BX\, United Kingdom
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251204T090000
DTEND;TZID=Europe/London:20251204T170000
DTSTAMP:20251027T134944Z
CREATED:20251027T134904Z
LAST-MODIFIED:20251027T134944Z
UID:8043-1764838800-1764867600@oncologynewstoday.co.uk
SUMMARY:Bladder Oncology Study Day
DESCRIPTION:Overview \nThis multidisciplinary educational event brings together renowned experts and healthcare professionals to explore the rapidly evolving landscape of bladder cancer management. As one of the most common urological malignancies\, bladder cancer presents unique challenges requiring coordinated care across multiple specialties. Our study day addresses critical developments in molecular diagnostics\, emerging therapeutic approaches\, and patient-centred care strategies that are transforming outcomes for patients \nWhat to expect \n\nApply current evidence-based approaches to bladder cancer management\nIntegrate new diagnostic and therapeutic strategies into clinical practice\nEnhance multidisciplinary team collaboration\nImprove patient counselling and shared decision-making\n\nAgenda \nTo be confirmed \nPlease note: one livestream ticket purchase is equivalent to one CPD certificate and the name on the ticket will match the one on the booking registration. Where the ‘5 for 4’ ticket option is purchased\, we will contact you directly to ask for the 5 names for the certificates. Further details can be found in our T&C’s further down this page. \nVenue Information \nThe Christie Education Centre is located on the 2nd floor in Dept 17 of the main hospital and can be accessed by stairs or lift. Toilets are also on this floor including an accessible toilet. The auditorium has a hearing loop available and ramp access. A prayer room is available and close by. We want everyone attending our event in person to have the best possible experience. We provide regular breaks\, access to quiet spaces etc\, but If there is anything else we can do to make the day/your experience more comfortable\, please let us know by either completing this form\, Inclusive learning support or emailing us: the-christie.learner.support@nhs.net \nPlease see our booking Terms and Conditions here \nClick here to read our privacy policy: http://www.christie.nhs.uk/professionals/education/continuing-professional-development/study-days-and-conferences/school-of-oncology-events-privacy-policy/ \nThis event may be subject to change from Hybrid to fully virtual. Correspondence in regards to any changes in the delivery of this event will be notified directly by The Christie Insttute for Cancer Education. \nEmail the-christie.educationevents@nhs.net or call +44 (0) 161 918 7409
URL:https://oncologynewstoday.co.uk/event/bladder-oncology-study-day/
LOCATION:The Christie School of Oncology\, 550 Wilmslow Road\, Manchester\, M20 4BX\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251203T090000
DTEND;TZID=Europe/London:20251203T170000
DTSTAMP:20251027T135951Z
CREATED:20251027T135951Z
LAST-MODIFIED:20251027T135951Z
UID:8045-1764752400-1764781200@oncologynewstoday.co.uk
SUMMARY:A User Guide to Cancer Immunotherapy Conference
DESCRIPTION:Following successful meetings from 2016 to 2024\, we are delighted to continue this face-to-face meeting for our User Guide to Cancer Immunotherapy Conference in December 2025. Our updated programme will provide an overview of immunotherapy\, with a focus on the recognition and management of immune-mediated toxicities. The meeting will have a strong clinical emphasis\, aimed at providing delegates with practical guidance that can be used in daily practice. As such\, it will be of value to healthcare professionals involved in the delivery of cancer care including doctors\, nurses\, pharmacists and physician associates working in oncology\, acute medicine\, emergency medicine\, medical specialties and general practice. We look forward to seeing you in December 2025.
URL:https://oncologynewstoday.co.uk/event/a-user-guide-to-cancer-immunotherapy-conference-2/
LOCATION:The Royal Marsden Education and Conference Centre\, Chelsea\, Stewart's Grove\, London\, SW3 6JJ\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251121T090000
DTEND;TZID=Europe/London:20251121T170000
DTSTAMP:20251114T104105Z
CREATED:20251114T104105Z
LAST-MODIFIED:20251114T104105Z
UID:8102-1763715600-1763744400@oncologynewstoday.co.uk
SUMMARY:Perineal Reconstruction Study Day
DESCRIPTION:Overview \nThis study day offers a comprehensive overview of surgical techniques for complex perineal reconstruction\, including a multidisciplinary approach. It covers both reconstructive and resectional aspects of the field\, including the role of radiology in preoperative planning and perioperative care. Lectures will discuss considerations in multi-organ removal and up to date avaiable reconstructive surgical options. \nListen to leading national and international experts from the fields of plastic surgery\, colorectal surgery\, urology\, and gyne-oncological surgery. Some presenters have specialties involved in the treatment of patients with perineal malignancies. \nAll available reconstructive options and detailed information on perineal and pelvic defects\, together with valuable insights into surgical execution\, indications\, and common complications and pitfalls encountered when dealing with these challenging defects\, will be highlighted. \nIntended Audience \n\nConsultant Plastic and Reconstructive Surgeons\nConsultant Colorectal and General Surgeons\nConsultant Gynaecological Oncological Surgeons\nConsultant Urologists\, Oncologists and Surgical\nNon-surgical trainees with an interest to learn about this challenging field\n\nJoin Your Colleagues: \n\nIn-person: Education Centre\, The Christie (easy access via local transport links)\nVirtual: Participate from your workplace\nCatch-up access: 6-month replay available – perfect for busy clinical schedules\n\nONCOLOGYNT – For 10% off
URL:https://oncologynewstoday.co.uk/event/perineal-reconstruction-study-day/
LOCATION:The Christie School of Oncology\, 550 Wilmslow Road\, Manchester\, M20 4BX\, United Kingdom
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251119T090000
DTEND;TZID=Europe/London:20251120T170000
DTSTAMP:20251020T051741Z
CREATED:20251020T051741Z
LAST-MODIFIED:20251020T051741Z
UID:8005-1763542800-1763658000@oncologynewstoday.co.uk
SUMMARY:European Cancer Summit 2025
DESCRIPTION:The European Cancer Summit 2025 will unite the cancer community for an exceptional edition\, fit for exceptional times. \nThe Summit this year will focus on the urgent need to secure sustained political and financial support for cancer as a health and societal priority. This multistakeholder forum provides a unique setting for healthcare professionals\, patients and policymakers to tackle challenges from every perspective and work together towards developing solutions and uncovering opportunities. \nThis year’s theme will underpin each session\, shaped by the work of the European Cancer Organisation (ECO) and its nine Focused Topic Networks: \nCancer in a Changing Global Landscape: Cancer care and research are being reshaped by global instability and shrinking support for international cooperation\, creating far-reaching challenges for Europe and beyond. \nChallenges & Commitments: As the political agenda of the European Union shifts to address geopolitical challenges\, the cancer community must rally – drawing strength from the achievements of Europe’s Beating Cancer Plan and the Cancer Mission – to ensure quality cancer care remains health priority but also a pillar of resilience\, innovation\, and strategic autonomy. \nThis year’s European Cancer Summit will be chaired by: \n\nKathy Oliver\, Co-Chair\, Patient Advisory Committee\, European Cancer Organisation\nNicolò Battisti\, Co-Chair\, Inequalities Network\, European Cancer Organisation
URL:https://oncologynewstoday.co.uk/event/european-cancer-summit-2025/
LOCATION:Brussels
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251119T090000
DTEND;TZID=Europe/London:20251120T170000
DTSTAMP:20251020T051008Z
CREATED:20251020T050420Z
LAST-MODIFIED:20251020T051008Z
UID:7998-1763542800-1763658000@oncologynewstoday.co.uk
SUMMARY:The 9th Royal Marsden Lung Cancer Symposium
DESCRIPTION:We have assembled a combination of highly knowledgeable faculty members who will be talking on topics including\, lung cancer screening\, biomarker testing\, systemic and local therapies in both NSCLC and SCLC. It will also involve discussions and debate on the pros and cons of treating oligometastatic NSCLC and put data in context with panel-based case-discussions. \nThis conference runs every 2 years with a multi-disciplinary audience composed of  all healthcare professionals including medical\, nursing and other allied healthcare professionals involved in the treatment and management of patients with lung cancer. \n6 CPD Points Awarded by the Royal College of Physicians \nCost: \n£200 Full Delegate \n£150 Trainees and CNSs
URL:https://oncologynewstoday.co.uk/event/the-9th-royal-marsden-lung-cancer-symposium/
LOCATION:London
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251114T080000
DTEND;TZID=Europe/London:20251115T170000
DTSTAMP:20251020T050916Z
CREATED:20251020T050916Z
LAST-MODIFIED:20251020T050916Z
UID:8002-1763107200-1763226000@oncologynewstoday.co.uk
SUMMARY:UKBCG Annual Meeting
DESCRIPTION:This meeting is for UKBCG (UK Breast Cancer Group) members only. The UKBCG Annual Meeting is aimed at Consultant Oncologists but is also open to Oncology Associate Specialists and SpRs. \nMembership is open to UK-based individuals approved by the Trustees including:  \n\nConsultant Clinical and Medical Oncologists\nSpecialty doctors\, postdoctoral research fellows\, career registrars in clinical or medical oncology\n\nIf you are eligible for membership and have not yet applied please do so here.  \nIf you are are unsure if you are already a member\, please contact ukbcg@profileproductions.co.uk. \nMemberships run from 1st January to 31st December each year. There is currently no annual charge for membership.
URL:https://oncologynewstoday.co.uk/event/ukbcg-annual-meeting/
LOCATION:London
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251112T080000
DTEND;TZID=Europe/London:20251114T170000
DTSTAMP:20251020T045747Z
CREATED:20251020T045601Z
LAST-MODIFIED:20251020T045747Z
UID:7994-1762934400-1763139600@oncologynewstoday.co.uk
SUMMARY:ESMO AI & Digital Oncology Congress 2025
DESCRIPTION:The ESMO AI & Digital Oncology Congress is the new forum organised by the European Society for Medical Oncology (ESMO) to provide an opportunity for scientific\, methodological\, regulatory\, policy and industry experts to connect and interact\, and to involve general cancer healthcare practitioners in discussions about AI and digital health. \nThe Congress will involve all stakeholders in a novel format that integrates education with the presentation of scientific breakthroughs\, in-depth discussions of complex issues\, and the showcasing of tools and applications that will ultimately develop a connected community of experts. \nLearning objectives\n\nTo inform oncology health care professionals on the latest scientific breakthroughs in the field of AI & Digital Oncology.\nTo connect expert groups allowing for interactions accelerating the development of innovative AI solutions in oncology.\nTo provide insights on transversal topics related to methodology\, ethics\, industry initiatives\, legal and regulatory considerations on AI & Digital Oncology.\n\nAccreditation\nESMO-MORA: The ESMO AI & Digital Oncology Congress 2025 programme will be submitted for ESMO-MORA category 1. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology.
URL:https://oncologynewstoday.co.uk/event/esmo-ai-digital-oncology-congress-2025/
LOCATION:Berlin
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251112T080000
DTEND;TZID=Europe/London:20251113T170000
DTSTAMP:20250326T091256Z
CREATED:20250326T091256Z
LAST-MODIFIED:20250326T091256Z
UID:7180-1762934400-1763053200@oncologynewstoday.co.uk
SUMMARY:10th Global Summit on Cancer Science & Therapy
DESCRIPTION:Inovine Meetings LLC extends a warm invitation for your participation in the upcoming 10th Global Summit on Cancer Science and Therapy scheduled for November 12 – 13\, 2025\, Barcelona\, Spain. The theme for this prestigious event is “Integrative Approaches in Cancer Science: Prevention\, Detection\, and Cure”. \nWe are thrilled to invite you to this exceptional gathering\, where you’ll connect with a diverse group of keynote speakers\, renowned experts\, and trailblazing researchers from around the world. This conference serves as a premier venue for sharing innovative ideas\, unveiling ground breaking research\, and cultivating collaborative ventures that will influence the future of Cancer Science. \nJoin us to engage with leading academics\, distinguished professors\, and dedicated delegates in an inspiring environment dedicated to advancing the field. Whether you’re here to present your latest findings or to gain insights from pioneers in Cancer Science\, this is an unparalleled opportunity to contribute to and learn from the global discourse on health. We look forward to your participation in shaping the future of Cancer Science at this landmark event. \nConference Highlights: \n\nResearchers Forum – Share your research with a global audience and receive expert feedback.\nIndustry Roundtables – Collaborate with cancer & oncology societies professionals and more\nOral & Poster Presentations – Present your innovative work on cancer science and therapy.\nCPD Accreditation – Earn CPD points to enhance your professional development.\nNetworking Lounge – Build partnerships that extend beyond the summit.\n\nKey Topics: \n\nCancer Research Therapy and Autoimmune Diseases\nCancer Biology and Biomarkers\nTypes and Causes of Cancer\nHematology in Cancer\nOrgan Specific Cancer\nCancer: Awareness\, Lifestyle and Nutrition\nOncology Subspecialties\nAdvancements in Cancer Imaging Technologies\nCancer Genomics and Epidemiology\nCancer and Immunology\n\nTarget Audience \n\nAcademicians\nOncologists\nPathologists\nCancer & Oncology Societies Professionals\nBio-Medical Company professionals\nCorporate Cancer Research Professional\nResearch Scholars\nPharmacists\nBusiness Entrepreneurs\nSoftware Developing Companies\nMedical Devices Companies\nBiotechnology Companies\n\nParticipation Formats \n\nOral Presentations – 20-minute talks + Q&A on cancer science and therapy topics\nPoster Presentations – Showcase your research findings visually\nWorkshops – 60-minute practical sessions on cancer science\nVirtual Presentations – Present remotely and receive a certificate with digital abstract publication\n\nThe conference covers a wide range of tracks\, including cancer science\, Cancer Research Therapy and Autoimmune Diseases\, Cancer Biology and Biomarkers\, Types and Causes of Cancer\, Hematology in Cancer\, Organ Specific Cancer\, and Cancer: Awareness\, Lifestyle and Nutrition\, Oncology Subspecialties\, Advancements in Cancer Imaging Technologies\, Cancer Genomics and Epidemiology\, and more. Attendees will have the opportunity to engage in parallel sessions\, network with renowned professionals\, and explore publishing prospects.
URL:https://oncologynewstoday.co.uk/event/10th-global-summit-on-cancer-science-therapy/
LOCATION:London
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251105T090000
DTEND;TZID=Europe/London:20251105T170000
DTSTAMP:20251114T122835Z
CREATED:20251114T122835Z
LAST-MODIFIED:20251114T122835Z
UID:8125-1762333200-1762362000@oncologynewstoday.co.uk
SUMMARY:Pathology Study Day
DESCRIPTION:Overview \nThe Pathology Study Day will provide a basic understanding of the broad range of services provided within Pathology\, highlighting the critical role of Pathology in clinical care pathways\, and expand knowledge on emerging technologies and areas of research. \n  \nIntended Audience \nAll users of the Pathology services. The Study Day is open to all health care professionals\, whether new to Pathology and Laboratory Medicine\, or those wanting a refresher on basic knowledge. \n  \nWhat to expect \n\nIntroduction to Histopathology\nDiagnostic Lymphoma Practice update\nCell Therapy in Haematology\nUse of Artificial Intelligence and Biomarker Research & Innovation.\nInteractive case sessions.\n\nJoin Your Colleagues: \n\nIn-person: Education Centre\, The Christie (easy access via local transport links)\nVirtual: Participate from your workplace\nCatch-up access: 6-month replay available – perfect for busy clinical schedules\n\n  \n  \nONCOLOGYNT – For 10% off
URL:https://oncologynewstoday.co.uk/event/pathology-study-day/
LOCATION:Education Centre (Dept 17) The Christie\, 550 Wilmslow Road\, Manchester\, M20 4BX
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251104T090000
DTEND;TZID=Europe/London:20251104T170000
DTSTAMP:20250902T075713Z
CREATED:20250902T075713Z
LAST-MODIFIED:20250902T075713Z
UID:7840-1762246800-1762275600@oncologynewstoday.co.uk
SUMMARY:UK Lung Cancer Coalition – UK Lung Cancer: 20 years on – what's next?
DESCRIPTION:UK Lung Cancer: 20 years on – what’s next? \n4th November\, Mary Ward House\, London \nJoin the UK Lung Cancer Coalition (UKLCC) at its 20th anniversary conference. Not only will the event provide an opportunity to take stock of two decades of campaigning and progress in driving quality improvements in lung cancer care – it will also provide a platform to discuss\, and agree\, critical priorities for UK lung cancer services treatment and survival for the next two decades (and beyond).  The event will feature presentations by clinical leadership from across the UK\, including flash talks and interactive breakout sessions on topics such as screening\, genomic testing\, health inequalities and rural medicine\, and cancer survivorship. There will also be a keynote speech from the National Cancer Director\, and the NHSE lung cancer screening team and Welsh screening lead will also provide latest updates. \nRegister here: https://www.uklcc.org.uk/conference/uk-lung-cancer-20-years-whats-next \nView the programme: https://www.uklcc.org.uk/conference/programme \nVenue: https://www.marywardhouse.com/
URL:https://oncologynewstoday.co.uk/event/uk-lung-cancer-coalition-uk-lung-cancer-20-years-on-whats-next/
LOCATION:Mary Ward House\, London
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251027T080000
DTEND;TZID=Europe/London:20251030T170000
DTSTAMP:20250731T120523Z
CREATED:20250731T115935Z
LAST-MODIFIED:20250731T120523Z
UID:7743-1761552000-1761843600@oncologynewstoday.co.uk
SUMMARY:8th Annual TPD & Induced Proximity Summit
DESCRIPTION:As the TPD field eagerly awaits the approval of Arvinas’s Vepdegestrant\, and with C4 Therapeutics and Kymera progressing through Phase 1 and 2 clinical trials\, 2025 is poised to be the year of clinical validation for TPD. This has been echoed in the flurry of partnerships worth over $200M in 2025 alone\, with the majority of big pharma now invested in molecular glues\, PROTACs\, or novel induced proximity drugs. \nReturning as the industry’s definitive forum from early discovery to clinical development\, the 8th Annual TPD & Induced Proximity Summit is the world’s largest and longest-standing forum for proximity-based modalities\, enabling you to fully immerse yourself in the breadth and depth of cutting-edge induced proximity therapeutic development. \nFeaturing key leaders such as Arvinas\, Nurix Therapeutics\, C4 Therapeutics\, and innovative newcomers including Larkspur Bio\, Magnet Biomedicine\, TrimTech Therapeutics\, as well as the co-founders of TPD\, Craig Crews and Ray Deshaies\, this is your ultimate meeting to hear the latest clinical data\, forge strategic relationships\, and capitalize on the huge opportunity for this modality to treat patients with high unmet clinical need.
URL:https://oncologynewstoday.co.uk/event/accelerating-the-discovery-development-approval-of-first-in-class-selective-safe-efficacious-degraders-proximity-based-drugs-to-target-the-undruggable/
LOCATION:Boston\, MA\, Hilton Boston Back Bay\, 40 Dalton Street\, Boston\, MA\, MA 02115\, United States
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251022T080000
DTEND;TZID=Europe/London:20251023T170000
DTSTAMP:20250731T121513Z
CREATED:20250731T121412Z
LAST-MODIFIED:20250731T121513Z
UID:7750-1761120000-1761238800@oncologynewstoday.co.uk
SUMMARY:3rd Spatial Biology for Drug Development Summit
DESCRIPTION:Welcome to the 3rd Spatial Biology for Drug Development Summit  \n\n\n\n\nSuccessfully De-risk Clinical Decision-Making\, Standardize Spatial Biology Applications & Navigate Infrastructure & Data Challenges to Accelerate Workflows with Greater Accuracy & Return on Investment \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nug deve \nThe 3rd Spatial Biology for Drug Development Summit is your opportunity to come together with leading biopharma experts to address these hurdles head-on. Across an intensive 2-day agenda\, you’ll explore practical solutions to issues spanning data infrastructure\, multi-omics integration\, standardization\, scalability\, and translation into the clinic. This year’s forum will equip you with the latest data-driven strategies to not only overcome obstacles but to maximize the value of spatial biology for deeper disease insights\, robust target identification\, biomarker discovery\, and more.
URL:https://oncologynewstoday.co.uk/event/3rd-spatial-biology-for-drug-development-summit/
LOCATION:Boston\, MA\, Hilton Boston Back Bay\, 40 Dalton Street\, Boston\, MA\, MA 02115\, United States
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251017T080000
DTEND;TZID=Europe/London:20251021T170000
DTSTAMP:20250930T142637Z
CREATED:20250930T142637Z
LAST-MODIFIED:20250930T142637Z
UID:7929-1760688000-1761066000@oncologynewstoday.co.uk
SUMMARY:ESMO Congress 2025
DESCRIPTION:The ESMO Congress is a highly influential global oncology platform for clinicians\, researchers\, patient advocates\, journalists and healthcare industry representatives from all over the world. \nESMO 2025 will be a place where groundbreaking discoveries\, cutting-edge treatments and a collaborative approach converge to shape the future of cancer care. \nYou will be able to learn from internationally renowned experts\, engage in thought-provoking discussions and connect with fellow oncology professionals that are driving advancements in diagnosis\, treatment and survivorship. \nSave the date for ESMO 2025\, taking place in Berlin\, Germany 17-21 October 2025.
URL:https://oncologynewstoday.co.uk/event/esmo-congress-2025/
LOCATION:Berlin
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251008T090000
DTEND;TZID=Europe/London:20251008T170000
DTSTAMP:20250514T145000Z
CREATED:20250514T145000Z
LAST-MODIFIED:20250514T145000Z
UID:7403-1759914000-1759942800@oncologynewstoday.co.uk
SUMMARY:UKASCC 2025 Supportive Oncology Conference
DESCRIPTION:Overview \nWe have brought together speakers from all over the globe to share their knowledge and expertise\, and we welcome delegates from all medical and allied health specialties to learn more about this fast growing field of oncology. The aim of this 3-day event is to provide a range of up to date\, evidence-based guidance on how to anticipate and manage problems associated with cancer and its treatment. \nIntended Audience \nMedical Trainees\, Clinical Nurse Specialists\, GP’s\, Oncologists\, Consultants \, General Physicians\, Emergency Physicians\, Research Nurses\, Acute Oncology Nurses\, Palliative Care Professionals and Allied Health Professionals (such as Radiographers\, Occupational Therapists\, Physiotherapists Dieticians) and any others working within Supportive Oncology \nWhat to expect \nMany exciting areas and topics will be presented and discussed\, some of which will include: \n\nLiving with and beyond cancer\nPaediatric/TYA supportive oncology\nSupportive Oncology in older adults\nHaematological malignancy\nTreatment toxicities\nCancer and the bowel\nLong term effects of opioids\nInequalities\nThe Supportive Oncology bigger picture\n\nAgenda \nPlease click here : https://christie-nhs.pagetiger.com/basydqt/1 \nVenue Information \nThe Bridgewater Hall \nLower Mosely Street \nManchester \nM2 3WS \nPlease click here for further venue information regarding accessibility and parking. \nThe venue is served by excellent public transport links and we encourage delegates to take advantage of this. Metrolink tram passengers should alight at St Peter’s Square or Deansgate-Castlefield. The nearest bus stops for major routes into the city centre are St Peter’s Square/Portland Street or Deansgate and the nearest rail stations are Deansgate and Oxford Road. \nWe want everyone attending our event in person to have the best possible experience. We provide regular breaks\, access to quiet spaces etc\, but If there is anything else we can do to make the day/your experience more comfortable\, please let us know. \nAccommodation in Manchester\, for a variety of budgets\, can be booked via online booking sites\, ‘Visit Manchester’ website has further information about the city. \nPlease note: one ticket purchase is equivalent to one CPD certificate and the name on the ticket will match the one on the booking registration. Further details can be found in our T&C’s. \nPlease see our booking Terms and Conditions here \nClick here to read our privacy policy: http://www.christie.nhs.uk/professionals/education/continuing-professional-development/study-days-and-conferences/school-of-oncology-events-privacy-policy/ \nThis event may be subject to change from Hybrid to fully virtual. Correspondence in regards to any changes in the delivery of this event will be notified directly by The School of Oncology. \nEmail the-christie.educationevents@nhs.net or call +44 (0) 161 446 3683
URL:https://oncologynewstoday.co.uk/event/ukascc-2025-supportive-oncology-conference/
LOCATION:The Bridgewater Hall\, The Bridgewater Hall\, Manchester\, M2 3WS
CATEGORIES:Oncology Events
END:VEVENT
END:VCALENDAR